发明申请
US20100189716A1 TREATMENT OF HODGKINS LYMPHOMA 审中-公开
HODGKINS LYMPHOMA的治疗

TREATMENT OF HODGKINS LYMPHOMA
摘要:
Compositions comprising CD80 antagonists and methods using these compositions are provided for the treatment of Hodgkins lymphoma. More particularly, the disclosed CD80 antagonists may be used to induce apoptosis or lysis of Hodgkins Reed-Sternberg (HRS) cells, or to inhibit HRS cell activities that promote tumor development or progression.
信息查询
0/0